Anna Gluskin
Directeur/Membre du Conseil chez EASTGATE BIOTECH CORP.
Profil
Anna E.
Gluskin is the founder.
She founded Generex Biotechnology Corp.
in 1995, where she served as the President & Chief Executive Officer until 2010.
Currently, Ms. Gluskin holds the position of Executive Chairman & Chief Executive Officer at Eastgate Biotech Corp.
since 2012 and Chief Executive Officer at Eastgate Pharmaceuticals, Inc. since 2011.
In the past, Ms. Gluskin worked as a Director at Protect Pharmaceutical Corp.
in 2010, Director at NuGenerex Immuno-Oncology, Inc. in 2011, Director at Generex Pharmaceuticals, Inc. in 2011, and Director at Interlock Consolidated Enterprises, Inc.Ms. Gluskin completed her graduate degree at the University of Toronto and Moscow State University Lomonosov.
Postes actifs de Anna Gluskin
| Sociétés | Poste | Début |
|---|---|---|
| EASTGATE BIOTECH CORP. | Directeur/Membre du Conseil | - |
Eastgate Pharmaceuticals, Inc.
 Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Directeur Général | 01/03/2011 |
Anciens postes connus de Anna Gluskin
| Sociétés | Poste | Fin |
|---|---|---|
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Directeur/Membre du Conseil | 14/01/2011 |
Generex Pharmaceuticals, Inc.
 Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Toronto, Canada. | Directeur/Membre du Conseil | 14/01/2011 |
| PROTECT PHARMACEUTICAL CORPORATION | Directeur/Membre du Conseil | 01/09/2010 |
| GENEREX BIOTECHNOLOGY CORPORATION | Directeur Général | 01/09/2010 |
| Interlock Consolidated Enterprises, Inc. | Directeur/Membre du Conseil | - |
Formation de Anna Gluskin
| Moscow State University Lomonosov | Graduate Degree |
| University of Toronto | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROTECT PHARMACEUTICAL CORPORATION | Transportation |
| EASTGATE BIOTECH CORP. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Generex Pharmaceuticals, Inc.
Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Toronto, Canada. | Health Technology |
NuGenerex Immuno-Oncology, Inc.
 NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
Eastgate Pharmaceuticals, Inc.
Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Health Technology |
| Interlock Consolidated Enterprises, Inc. | |
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
